CClinicalTrials.gg
RecruitingNCT05948696Updated Jul 17, 2023

Experience of Horticultural Group Therapy Among People With Chronic Schizophrenia

An observational study in Chronic Schizophrenia, sponsored by TsaoTun Psychiatric Center, Department of Health, Taiwan. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-07-17.

Sponsored by TsaoTun Psychiatric Center, Department of Health, Taiwan · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years 1 month ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 4 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
10
Ages
20 Years and older
Sex
All
01

Study summary

Taiwan National Health Insurance Administration database shows that the number of people seeking medical treatment due to mental illness has reached 1.454 million in 2021. The annual growth rate of mental illness is between 3.3% to 6.6%. Fifty percent of mental illness patient has catastrophic illness certificate because of chronic schizophrenia (Ministry of Health and Welfare,2022). Auditory hallucinations, delusions, emotional disturbances, and disorder in behavior and the poor ability of speaking are common in patients with schizophrenia. These symptoms lead to reduce the cognitive and executive function, resulting severe impairment of eventual daily living functions and social interactions. Thus, the cost of hospitalization and medical fee is increased. It is worth considering the appropriateness of the model of care. According to researches, people with schizophrenia still strive to pursue a happy and satisfying life. However, statistics of satisfaction and happiness are still lower than people who are healthy (Palmer et al., 2014; Fervaha et al., 2016).

The American Horticultural Therapy Association (AHTA) pointed out that horticultural therapy increases the well-being of participants through active or passive participation in plant-related activities. It also helps participants learn new skills or regain lost skills. Furthermore, psychiatric symptoms, recovery outcomes, life satisfaction, and the benefits of social function are significantly improved (Lu et al., 2021; Oh et al., 2018). Taiwanese scholars mention that combining horticultural activities and group psychotherapy improves the therapeutic results. It means that using of flowers and plants in gardening combines with the therapeutic advantages of group psychotherapy, mental illness patients can benefit more from it (Lin, 2016).

This study aims to explore the experience of patients with chronic schizophrenia participating in horticultural group therapy. This research design adopts the purposive sampling in qualitative method from a psychiatric hospital in central Taiwan. It is expected that 10 participants will involve in 12 times of horticultural therapy, and recordings will be made in each group. After 12 times of the therapy, participants will be involved in semi-structured audio-recorded interviews. The collected data were analyzed step by step using the content analysis method. In addition, participants will finish the questionnaires of the "Mental Well-Being Scale"," Satisfaction With Life Scale ", " activity of daily living Scale ", Instrumental Activities of Daily Living Scale", and "Group Efficacy Observation Form" before and after the therapies. The data will be conducted with descriptive statistics, Pearson's correlation coefficient, Chi-square Test, Paired Sample t test by using SPSS 21.0 statistical software. This research hopes to understand the impact of horticultural treatments in people who suffer from chronic schizophrenia, and provides a reference to clinical teams.

02

Conditions studied

  • Chronic Schizophrenia

Browse trials for

Keywords

  • chronic schizophrenia, horticultural therapy group
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's planned enrollment of 10 is below the median of 178 across 491 observational studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

TsaoTun Psychiatric Center, Department of Health, Taiwan is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Persons with schizophrenia and have been hospitalized to for more than 6 months.

Inclusion criteria

  • Persons with schizophrenia and have been hospitalized to for more than 6 months.
  • Intact or minimal cognitive performance on SPMSQ.
  • Mild to moderate severity on Brief Psychiatric Rating Scale.
  • ADL score>65 on Barthel Index
  • Moderate or low on the Warwick-Edinburg Mental Well-being scale

Exclusion criteria

Exclusion Criteria:

  • Those who are not able to comply with the requirements of the study
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
10 participants (estimated)
Patient registry
No

Groups and cohorts

  • Horticultural participants

    Inpatients with chronic schizophrenia who attend to a horticultural group therapeutic program.

    Behavioral: Horticultural group therapy.

Interventions

  • BehavioralHorticultural group therapy.

    Estimated 10 persons with schizophrenia who attend to a 12-week horticultural group therapy will be assessed for their experience about the program.

06

What researchers measure

Primary outcomes

  1. Well-being

    Measured with the Warwick-Edinburg Mental Well-being scale

    Time frame: 12 weeks

Secondary outcomes

  1. Basic and instrumental activities of daily living

    Time frame: 12 weeks

Other outcomes

  1. Group Efficacy

    Measured by Group Efficacy Observation Form

    Time frame: 12 weeks

07

Study locations

1 of 1 sites recruiting
  • TsaoTun Psychiatric Center
    Nantou, 54249, Taiwan
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05948696
Lead sponsor
TsaoTun Psychiatric Center, Department of Health, Taiwan
Responsible party
Ying-Jyun Shih (MSc, TsaoTun Psychiatric Center, Department of Health, Taiwan) — Principal investigator
First posted
Jul 17, 2023
Start date
Jun 6, 2023
Primary completion
Sep 6, 2023 (estimated)
Completion
Sep 29, 2023 (estimated)
Last update
Jul 17, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion